Prognostic significance of vascular endothelial growth factor, tumor necrosis, and mitotic activity index in malignant pleural mesothelioma

被引:76
作者
Demirag, F
Ünsal, E
Yilmaz, A
Çaglar, A
机构
[1] Ataturk Chest Dis & Chest Surg Educ & Res Hosp, Dept Pathol, Ankara, Turkey
[2] Ataturk Chest Dis & Chest Surg Educ & Res Hosp, Dept Chest Dis, Ankara, Turkey
[3] Kafkas Univ, Sci & Art Fac, Dept Stat, Kars, Turkey
关键词
malignant mesothelioma; mitosis; prognosis; tumor necrosis; vascular endothelial growth factor;
D O I
10.1378/chest.128.5.3382
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: Tumor growth and metastasis are angiogenesis-dependent events, and several prognostic factors have been determined in malignant mesothelioma. In this study, we investigated the prognostic significance of vascular endothelial growth factor (VEGF), tumor necrosis (TN), and mitotic activity index (MAI) in malignant mesothelioma. For the first time (to our knowledge), we also demonstrated the association between VEGF staining, TN, and MAI in malignant mesothelioma. Methods: Decortication and VATS materials of 40 patients were investigated. The routinely processed formalin-fixed, paraffin-embedded, hematoxylin-eosin-stained tumor sections that had been used for the original diagnostic purposes were retrieved. Hematoxylin-eosin sections were selected for VEGF immunostaining, TN, and mitotic count. Clinicopathologic data, stage of disease, and survival of patients were all determined. The correlations between variables were evaluated by Spearman rank correlation test. Both univariate analysis using the log-rank test and multivariate analysis using Cox regression model were performed for survival analysis. Results: There was a significant correlation between VEGF staining and TIN (r = 0.42, p = 0.006). In univariate analysis, both VEGF staining (p = 0.0002) and TN (p = 0.0055) showed significant correlation with short survival. Also, there was a positive correlation between VEGF and tumor stage (p = 0.046). In multivariate analysis, only VEGF was determined as an independent prognostic factor in malignant mesothelioma (p = 0.001). There was no association between MAI and survival (p = 0.504). Conclusions: VEGF, known as an important angiogenic peptide, is an independent prognostic factor in malignant pleural mesothelioma. TN stimulates angiogenesis, and we observed a significant correlation between VEGF and TN. However, further studies are needed to evaluate the prognostic significance of angiogenic properties in malignant mesothelioma.
引用
收藏
页码:3382 / 3387
页数:6
相关论文
共 50 条
  • [31] Prognostic significance of vascular endothelial growth factor and its receptors in endometrial carcinoma
    Yokoyama, Y
    Sato, S
    Futagami, M
    Fukushi, Y
    Sakamoto, T
    Umemoto, M
    Saito, Y
    GYNECOLOGIC ONCOLOGY, 2000, 77 (03) : 413 - 418
  • [32] Vascular endothelial growth factor and protein level in pleural effusion for differentiating malignant from benign pleural effusion
    Wu, Da-Wei
    Chang, Wei-An
    Liu, Kuan-Ting
    Yen, Meng-Chi
    Kuo, Po-Lin
    ONCOLOGY LETTERS, 2017, 14 (03) : 3657 - 3662
  • [33] Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma
    Pan, Jianji
    Tang, Tianlan
    Xu, Luying
    Lu, Jiade J.
    Lin, Senan
    Qiu, Sufang
    Chen, Gang
    Tham, Ivan W. K.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (09): : 1238 - 1247
  • [34] CD74: a new prognostic factor for patients with malignant pleural mesothelioma
    C Otterstrom
    A Soltermann
    I Opitz
    E Felley-Bosco
    W Weder
    R A Stahel
    F Triponez
    J H Robert
    V Serre-Beinier
    British Journal of Cancer, 2014, 110 : 2040 - 2046
  • [35] CD74: a new prognostic factor for patients with malignant pleural mesothelioma
    Otterstrom, C.
    Soltermann, A.
    Opitz, I.
    Felley-Bosco, E.
    Weder, W.
    Stahel, R. A.
    Triponez, F.
    Robert, J. H.
    Serre-Beinier, V.
    BRITISH JOURNAL OF CANCER, 2014, 110 (08) : 2040 - 2046
  • [36] Tryptase Mast Cells in Malignant Pleural Mesothelioma as an Independent Favorable Prognostic Factor
    Ali, Greta
    Boldrini, Laura
    Lucchi, Marco
    Mussi, Alfredo
    Corsi, Valentina
    Fontanini, Gabriella
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (03) : 348 - 354
  • [37] Epidermal growth factor receptor mutations in malignant pleural and peritoneal mesothelioma
    Enomoto, Yasunori
    Kasai, Takahiko
    Takeda, Maiko
    Takano, Masato
    Morita, Kohei
    Kadota, Eiji
    Iizuka, Norishige
    Maruyama, Hiroshi
    Haratake, Joji
    Kojima, Yu
    Ikeda, Naoya
    Inatsugi, Naoki
    Nonomura, Akitaka
    JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (06) : 522 - 527
  • [38] Diagnostic accuracy of vascular endothelial growth factor for malignant pleural effusion: A meta-analysis
    Shen, Yong-Chun
    Liu, Meng-Qi
    Wan, Chun
    Chen, Lei
    Wang, Tao
    Wen, Fu-Qiang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 3 (06) : 1072 - 1076
  • [39] The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma
    Proto, Claudia
    Signorelli, Diego
    Mallone, Sandra
    Prelaj, Arsela
    Lo Russo, Giuseppe
    Imbimbo, Martina
    Galli, Giulia
    Ferrara, Roberto
    Ganzinelli, Monica
    Leuzzi, Giovanni
    Greco, Francesca Gabriella
    Calareso, Giuseppina
    Botta, Laura
    Gatta, Gemma
    Garassino, Marina
    Trama, Annalisa
    CLINICAL LUNG CANCER, 2019, 20 (06) : E652 - E660
  • [40] Cellular vascular endothelial growth factor and serum angiogenin in acute myeloid leukemia: clinical and prognostic significance
    Ismail, Mona A.
    Eissa, Deena Samir
    Heiba, Nihal M.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2013, 38 (01) : 41 - 46